Halozyme Therapeutics | HALO - Srodki Pieniężne I Ekwiwalent

Cena Akcji
63.83
Dzienna Zmiana
0.77 1.22%
Miesięcznie
-1.24%
Rocznie
6.33%
Q2 Prognozy TE
63.96




Srodki Pieniężne I Ekwiwalent Zmiana Data
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Agios Pharmaceuticals USD 113.6M 24.47M 2026-03
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
Amarin USD 131.06M 3.6M 2026-03
Amgen USD 9.13B 316M 2025-12
Baxter International USD 1.97B 240M 2025-12
Cara Therapeutics USD 21.42M 770K 2025-09
Cytokinetics USD 122.52M 102.95M 2025-12
DBV Technologies USD 194.17M 124.33M 2025-12
Eli Lilly USD 5.28B 1.99B 2026-03
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Halozyme Therapeutics USD 133.82M 285.84M 2025-12
Intrexon USD 9.34M 1.77M 2024-06
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
MannKind USD 74.88M 52.51M 2025-12
Minerva Neurosciences USD 82.3M 70.02M 2025-12
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Pfizer USD 1.34B 295M 2025-09
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
United Therapeutics USD 1.56B 217M 2025-12
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12